nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—RALBP1—Vincristine—muscle cancer	0.327	0.383	CbGbCtD
Carbamazepine—RALBP1—Doxorubicin—muscle cancer	0.204	0.24	CbGbCtD
Carbamazepine—ABCC2—Vincristine—muscle cancer	0.0343	0.0402	CbGbCtD
Carbamazepine—ABCC2—Etoposide—muscle cancer	0.0314	0.0369	CbGbCtD
Carbamazepine—CYP1A2—Dacarbazine—muscle cancer	0.024	0.0281	CbGbCtD
Carbamazepine—CYP3A7—Vincristine—muscle cancer	0.0229	0.0269	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0229	0.0269	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—muscle cancer	0.0214	0.0251	CbGbCtD
Carbamazepine—ABCC2—Methotrexate—muscle cancer	0.0208	0.0244	CbGbCtD
Carbamazepine—ABCB1—Dactinomycin—muscle cancer	0.0182	0.0213	CbGbCtD
Carbamazepine—CYP3A5—Vincristine—muscle cancer	0.0172	0.0201	CbGbCtD
Carbamazepine—CYP3A5—Etoposide—muscle cancer	0.0157	0.0185	CbGbCtD
Carbamazepine—CYP2C8—Etoposide—muscle cancer	0.0151	0.0178	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—muscle cancer	0.0136	0.016	CbGbCtD
Carbamazepine—CYP1A2—Etoposide—muscle cancer	0.0117	0.0137	CbGbCtD
Carbamazepine—ABCB1—Vincristine—muscle cancer	0.0112	0.0131	CbGbCtD
Carbamazepine—ABCB1—Etoposide—muscle cancer	0.0102	0.012	CbGbCtD
Carbamazepine—ABCB1—Doxorubicin—muscle cancer	0.00699	0.0082	CbGbCtD
Carbamazepine—ABCB1—Methotrexate—muscle cancer	0.00677	0.00794	CbGbCtD
Carbamazepine—CYP3A4—Vincristine—muscle cancer	0.0067	0.00786	CbGbCtD
Carbamazepine—CYP3A4—Etoposide—muscle cancer	0.00614	0.0072	CbGbCtD
Carbamazepine—CYP3A4—Doxorubicin—muscle cancer	0.00419	0.00491	CbGbCtD
Carbamazepine—RALBP1—smooth muscle tissue—muscle cancer	0.000695	0.0518	CbGeAlD
Carbamazepine—Nepafenac—PTGS2—muscle cancer	0.00067	0.275	CrCbGaD
Carbamazepine—UGT2B7—renal system—muscle cancer	0.000669	0.0498	CbGeAlD
Carbamazepine—RALBP1—renal system—muscle cancer	0.000669	0.0498	CbGeAlD
Carbamazepine—Magnesium salicylate—PTGS2—muscle cancer	0.000655	0.269	CrCbGaD
Carbamazepine—SCN4A—renal system—muscle cancer	0.000616	0.0459	CbGeAlD
Carbamazepine—RALBP1—cardiac atrium—muscle cancer	0.000599	0.0446	CbGeAlD
Carbamazepine—Salsalate—PTGS2—muscle cancer	0.000557	0.228	CrCbGaD
Carbamazepine—Oxaprozin—PTGS2—muscle cancer	0.000557	0.228	CrCbGaD
Carbamazepine—SCN9A—tendon—muscle cancer	0.000539	0.0402	CbGeAlD
Carbamazepine—RALBP1—tendon—muscle cancer	0.000522	0.0389	CbGeAlD
Carbamazepine—RALBP1—bone marrow—muscle cancer	0.000506	0.0377	CbGeAlD
Carbamazepine—RALBP1—vagina—muscle cancer	0.000484	0.0361	CbGeAlD
Carbamazepine—SCN4A—tendon—muscle cancer	0.000481	0.0359	CbGeAlD
Carbamazepine—RALBP1—head—muscle cancer	0.000447	0.0333	CbGeAlD
Carbamazepine—SCN9A—testis—muscle cancer	0.000447	0.0333	CbGeAlD
Carbamazepine—RALBP1—testis—muscle cancer	0.000432	0.0322	CbGeAlD
Carbamazepine—UGT2B7—testis—muscle cancer	0.000432	0.0322	CbGeAlD
Carbamazepine—SCN5A—cardiac atrium—muscle cancer	0.000428	0.0319	CbGeAlD
Carbamazepine—SCN4A—head—muscle cancer	0.000412	0.0307	CbGeAlD
Carbamazepine—SCN4A—testis—muscle cancer	0.000398	0.0297	CbGeAlD
Carbamazepine—ABCC2—renal system—muscle cancer	0.000359	0.0267	CbGeAlD
Carbamazepine—SCN5A—vagina—muscle cancer	0.000346	0.0258	CbGeAlD
Carbamazepine—SCN5A—head—muscle cancer	0.00032	0.0238	CbGeAlD
Carbamazepine—ABCC2—tendon—muscle cancer	0.00028	0.0209	CbGeAlD
Carbamazepine—CYP2C8—renal system—muscle cancer	0.000269	0.02	CbGeAlD
Carbamazepine—CYP1A2—renal system—muscle cancer	0.000252	0.0188	CbGeAlD
Carbamazepine—CYP3A5—renal system—muscle cancer	0.000243	0.0181	CbGeAlD
Carbamazepine—CYP2B6—renal system—muscle cancer	0.000241	0.018	CbGeAlD
Carbamazepine—ABCC2—testis—muscle cancer	0.000232	0.0173	CbGeAlD
Carbamazepine—CYP2C19—vagina—muscle cancer	0.000223	0.0166	CbGeAlD
Carbamazepine—CYP2C8—vagina—muscle cancer	0.000195	0.0145	CbGeAlD
Carbamazepine—Fatigue—Vincristine—muscle cancer	0.000191	0.00146	CcSEcCtD
Carbamazepine—Convulsion—Etoposide—muscle cancer	0.000191	0.00145	CcSEcCtD
Carbamazepine—Hyponatraemia—Doxorubicin—muscle cancer	0.00019	0.00145	CcSEcCtD
Carbamazepine—Hypertension—Etoposide—muscle cancer	0.00019	0.00145	CcSEcCtD
Carbamazepine—Pain—Vincristine—muscle cancer	0.00019	0.00144	CcSEcCtD
Carbamazepine—Constipation—Vincristine—muscle cancer	0.00019	0.00144	CcSEcCtD
Carbamazepine—Diplopia—Doxorubicin—muscle cancer	0.00019	0.00144	CcSEcCtD
Carbamazepine—Osteoarthritis—Doxorubicin—muscle cancer	0.00019	0.00144	CcSEcCtD
Carbamazepine—Chest pain—Etoposide—muscle cancer	0.000187	0.00143	CcSEcCtD
Carbamazepine—Eosinophilia—Methotrexate—muscle cancer	0.000187	0.00143	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000186	0.00142	CcSEcCtD
Carbamazepine—Pancreatitis—Methotrexate—muscle cancer	0.000186	0.00141	CcSEcCtD
Carbamazepine—Hypersensitivity—Dactinomycin—muscle cancer	0.000183	0.00139	CcSEcCtD
Carbamazepine—CYP3A4—renal system—muscle cancer	0.000182	0.0136	CbGeAlD
Carbamazepine—Abdominal discomfort—Methotrexate—muscle cancer	0.000181	0.00138	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Vincristine—muscle cancer	0.000181	0.00138	CcSEcCtD
Carbamazepine—Confusional state—Etoposide—muscle cancer	0.000181	0.00138	CcSEcCtD
Carbamazepine—Cardiac arrest—Doxorubicin—muscle cancer	0.00018	0.00137	CcSEcCtD
Carbamazepine—Pancytopenia—Methotrexate—muscle cancer	0.00018	0.00137	CcSEcCtD
Carbamazepine—Anaphylactic shock—Etoposide—muscle cancer	0.00018	0.00137	CcSEcCtD
Carbamazepine—Infection—Etoposide—muscle cancer	0.000178	0.00136	CcSEcCtD
Carbamazepine—Ataxia—Doxorubicin—muscle cancer	0.000178	0.00136	CcSEcCtD
Carbamazepine—Asthenia—Dactinomycin—muscle cancer	0.000178	0.00136	CcSEcCtD
Carbamazepine—Thrombocytopenia—Etoposide—muscle cancer	0.000176	0.00134	CcSEcCtD
Carbamazepine—CYP3A5—vagina—muscle cancer	0.000176	0.0131	CbGeAlD
Carbamazepine—Tachycardia—Etoposide—muscle cancer	0.000175	0.00134	CcSEcCtD
Carbamazepine—Abdominal pain—Vincristine—muscle cancer	0.000175	0.00134	CcSEcCtD
Carbamazepine—Body temperature increased—Vincristine—muscle cancer	0.000175	0.00134	CcSEcCtD
Carbamazepine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000175	0.00133	CcSEcCtD
Carbamazepine—CYP2B6—vagina—muscle cancer	0.000175	0.013	CbGeAlD
Carbamazepine—Skin disorder—Etoposide—muscle cancer	0.000174	0.00133	CcSEcCtD
Carbamazepine—Erectile dysfunction—Methotrexate—muscle cancer	0.000174	0.00133	CcSEcCtD
Carbamazepine—CYP2C8—testis—muscle cancer	0.000174	0.013	CbGeAlD
Carbamazepine—Hyperhidrosis—Etoposide—muscle cancer	0.000174	0.00132	CcSEcCtD
Carbamazepine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000173	0.00132	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000173	0.00132	CcSEcCtD
Carbamazepine—Hypokalaemia—Doxorubicin—muscle cancer	0.000173	0.00131	CcSEcCtD
Carbamazepine—Anorexia—Etoposide—muscle cancer	0.000171	0.0013	CcSEcCtD
Carbamazepine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000171	0.0013	CcSEcCtD
Carbamazepine—ABCB1—embryo—muscle cancer	0.00017	0.0127	CbGeAlD
Carbamazepine—Diarrhoea—Dactinomycin—muscle cancer	0.00017	0.00129	CcSEcCtD
Carbamazepine—Pneumonia—Methotrexate—muscle cancer	0.00017	0.00129	CcSEcCtD
Carbamazepine—Infestation NOS—Methotrexate—muscle cancer	0.000169	0.00129	CcSEcCtD
Carbamazepine—Infestation—Methotrexate—muscle cancer	0.000169	0.00129	CcSEcCtD
Carbamazepine—Drowsiness—Methotrexate—muscle cancer	0.000169	0.00129	CcSEcCtD
Carbamazepine—Depression—Methotrexate—muscle cancer	0.000168	0.00128	CcSEcCtD
Carbamazepine—Hypotension—Etoposide—muscle cancer	0.000168	0.00128	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000167	0.00127	CcSEcCtD
Carbamazepine—Muscular weakness—Doxorubicin—muscle cancer	0.000167	0.00127	CcSEcCtD
Carbamazepine—Renal failure—Methotrexate—muscle cancer	0.000166	0.00126	CcSEcCtD
Carbamazepine—Stomatitis—Methotrexate—muscle cancer	0.000164	0.00125	CcSEcCtD
Carbamazepine—Conjunctivitis—Methotrexate—muscle cancer	0.000164	0.00125	CcSEcCtD
Carbamazepine—Dysphagia—Doxorubicin—muscle cancer	0.000164	0.00125	CcSEcCtD
Carbamazepine—Hypersensitivity—Vincristine—muscle cancer	0.000163	0.00124	CcSEcCtD
Carbamazepine—Eosinophilia—Doxorubicin—muscle cancer	0.000162	0.00124	CcSEcCtD
Carbamazepine—CYP2B6—head—muscle cancer	0.000161	0.012	CbGeAlD
Carbamazepine—Paraesthesia—Etoposide—muscle cancer	0.000161	0.00123	CcSEcCtD
Carbamazepine—Haematuria—Methotrexate—muscle cancer	0.000161	0.00123	CcSEcCtD
Carbamazepine—Pancreatitis—Doxorubicin—muscle cancer	0.000161	0.00122	CcSEcCtD
Carbamazepine—Dyspnoea—Etoposide—muscle cancer	0.00016	0.00122	CcSEcCtD
Carbamazepine—Somnolence—Etoposide—muscle cancer	0.00016	0.00122	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Methotrexate—muscle cancer	0.00016	0.00122	CcSEcCtD
Carbamazepine—Asthenia—Vincristine—muscle cancer	0.000159	0.00121	CcSEcCtD
Carbamazepine—Vomiting—Dactinomycin—muscle cancer	0.000158	0.0012	CcSEcCtD
Carbamazepine—Bronchitis—Doxorubicin—muscle cancer	0.000158	0.0012	CcSEcCtD
Carbamazepine—Agranulocytosis—Methotrexate—muscle cancer	0.000157	0.0012	CcSEcCtD
Carbamazepine—Rash—Dactinomycin—muscle cancer	0.000157	0.00119	CcSEcCtD
Carbamazepine—Decreased appetite—Etoposide—muscle cancer	0.000156	0.00119	CcSEcCtD
Carbamazepine—CYP2B6—testis—muscle cancer	0.000156	0.0116	CbGeAlD
Carbamazepine—Pancytopenia—Doxorubicin—muscle cancer	0.000156	0.00119	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000155	0.00118	CcSEcCtD
Carbamazepine—Fatigue—Etoposide—muscle cancer	0.000155	0.00118	CcSEcCtD
Carbamazepine—Constipation—Etoposide—muscle cancer	0.000154	0.00117	CcSEcCtD
Carbamazepine—Pain—Etoposide—muscle cancer	0.000154	0.00117	CcSEcCtD
Carbamazepine—Diarrhoea—Vincristine—muscle cancer	0.000152	0.00116	CcSEcCtD
Carbamazepine—Hepatitis—Methotrexate—muscle cancer	0.000151	0.00115	CcSEcCtD
Carbamazepine—Pollakiuria—Doxorubicin—muscle cancer	0.000151	0.00115	CcSEcCtD
Carbamazepine—Pharyngitis—Methotrexate—muscle cancer	0.00015	0.00114	CcSEcCtD
Carbamazepine—Urinary tract disorder—Methotrexate—muscle cancer	0.00015	0.00114	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00015	0.00114	CcSEcCtD
Carbamazepine—Weight increased—Doxorubicin—muscle cancer	0.000149	0.00114	CcSEcCtD
Carbamazepine—Urethral disorder—Methotrexate—muscle cancer	0.000148	0.00113	CcSEcCtD
Carbamazepine—Feeling abnormal—Etoposide—muscle cancer	0.000148	0.00113	CcSEcCtD
Carbamazepine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000148	0.00113	CcSEcCtD
Carbamazepine—Nausea—Dactinomycin—muscle cancer	0.000147	0.00112	CcSEcCtD
Carbamazepine—Pneumonia—Doxorubicin—muscle cancer	0.000147	0.00112	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Etoposide—muscle cancer	0.000147	0.00112	CcSEcCtD
Carbamazepine—Dizziness—Vincristine—muscle cancer	0.000147	0.00112	CcSEcCtD
Carbamazepine—Infestation—Doxorubicin—muscle cancer	0.000146	0.00111	CcSEcCtD
Carbamazepine—Drowsiness—Doxorubicin—muscle cancer	0.000146	0.00111	CcSEcCtD
Carbamazepine—Infestation NOS—Doxorubicin—muscle cancer	0.000146	0.00111	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000145	0.0011	CcSEcCtD
Carbamazepine—Renal failure—Doxorubicin—muscle cancer	0.000144	0.00109	CcSEcCtD
Carbamazepine—Erythema multiforme—Methotrexate—muscle cancer	0.000143	0.00109	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000143	0.00109	CcSEcCtD
Carbamazepine—Urticaria—Etoposide—muscle cancer	0.000143	0.00109	CcSEcCtD
Carbamazepine—Stomatitis—Doxorubicin—muscle cancer	0.000142	0.00108	CcSEcCtD
Carbamazepine—Jaundice—Doxorubicin—muscle cancer	0.000142	0.00108	CcSEcCtD
Carbamazepine—Abdominal pain—Etoposide—muscle cancer	0.000142	0.00108	CcSEcCtD
Carbamazepine—Body temperature increased—Etoposide—muscle cancer	0.000142	0.00108	CcSEcCtD
Carbamazepine—Conjunctivitis—Doxorubicin—muscle cancer	0.000142	0.00108	CcSEcCtD
Carbamazepine—Urinary tract infection—Doxorubicin—muscle cancer	0.000142	0.00108	CcSEcCtD
Carbamazepine—Eye disorder—Methotrexate—muscle cancer	0.000142	0.00108	CcSEcCtD
Carbamazepine—Tinnitus—Methotrexate—muscle cancer	0.000141	0.00108	CcSEcCtD
Carbamazepine—Vomiting—Vincristine—muscle cancer	0.000141	0.00107	CcSEcCtD
Carbamazepine—Cardiac disorder—Methotrexate—muscle cancer	0.000141	0.00107	CcSEcCtD
Carbamazepine—Rash—Vincristine—muscle cancer	0.00014	0.00107	CcSEcCtD
Carbamazepine—Dermatitis—Vincristine—muscle cancer	0.00014	0.00106	CcSEcCtD
Carbamazepine—Haematuria—Doxorubicin—muscle cancer	0.000139	0.00106	CcSEcCtD
Carbamazepine—Headache—Vincristine—muscle cancer	0.000139	0.00106	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000138	0.00105	CcSEcCtD
Carbamazepine—Angiopathy—Methotrexate—muscle cancer	0.000137	0.00105	CcSEcCtD
Carbamazepine—Sinusitis—Doxorubicin—muscle cancer	0.000137	0.00104	CcSEcCtD
Carbamazepine—Immune system disorder—Methotrexate—muscle cancer	0.000137	0.00104	CcSEcCtD
Carbamazepine—Mediastinal disorder—Methotrexate—muscle cancer	0.000136	0.00104	CcSEcCtD
Carbamazepine—Agranulocytosis—Doxorubicin—muscle cancer	0.000136	0.00104	CcSEcCtD
Carbamazepine—Chills—Methotrexate—muscle cancer	0.000136	0.00104	CcSEcCtD
Carbamazepine—Alopecia—Methotrexate—muscle cancer	0.000134	0.00102	CcSEcCtD
Carbamazepine—Bradycardia—Doxorubicin—muscle cancer	0.000134	0.00102	CcSEcCtD
Carbamazepine—Mental disorder—Methotrexate—muscle cancer	0.000133	0.00101	CcSEcCtD
Carbamazepine—Hypersensitivity—Etoposide—muscle cancer	0.000132	0.00101	CcSEcCtD
Carbamazepine—Malnutrition—Methotrexate—muscle cancer	0.000132	0.001	CcSEcCtD
Carbamazepine—Erythema—Methotrexate—muscle cancer	0.000132	0.001	CcSEcCtD
Carbamazepine—Nausea—Vincristine—muscle cancer	0.000132	0.001	CcSEcCtD
Carbamazepine—Rhinitis—Doxorubicin—muscle cancer	0.000131	0.001	CcSEcCtD
Carbamazepine—Hepatitis—Doxorubicin—muscle cancer	0.000131	0.000999	CcSEcCtD
Carbamazepine—Pharyngitis—Doxorubicin—muscle cancer	0.00013	0.000991	CcSEcCtD
Carbamazepine—Urinary tract disorder—Doxorubicin—muscle cancer	0.00013	0.000987	CcSEcCtD
Carbamazepine—Oedema peripheral—Doxorubicin—muscle cancer	0.000129	0.000984	CcSEcCtD
Carbamazepine—Dysgeusia—Methotrexate—muscle cancer	0.000129	0.000983	CcSEcCtD
Carbamazepine—ABCB1—renal system—muscle cancer	0.000129	0.00961	CbGeAlD
Carbamazepine—Asthenia—Etoposide—muscle cancer	0.000129	0.000982	CcSEcCtD
Carbamazepine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000129	0.000982	CcSEcCtD
Carbamazepine—Urethral disorder—Doxorubicin—muscle cancer	0.000129	0.000979	CcSEcCtD
Carbamazepine—Back pain—Methotrexate—muscle cancer	0.000128	0.000971	CcSEcCtD
Carbamazepine—Pruritus—Etoposide—muscle cancer	0.000127	0.000968	CcSEcCtD
Carbamazepine—Vision blurred—Methotrexate—muscle cancer	0.000124	0.000946	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—muscle cancer	0.000124	0.000945	CcSEcCtD
Carbamazepine—Diarrhoea—Etoposide—muscle cancer	0.000123	0.000936	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—muscle cancer	0.000123	0.000934	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—muscle cancer	0.000122	0.000931	CcSEcCtD
Carbamazepine—Anaemia—Methotrexate—muscle cancer	0.000122	0.000928	CcSEcCtD
Carbamazepine—Cardiac disorder—Doxorubicin—muscle cancer	0.000122	0.000927	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—muscle cancer	0.000122	0.000927	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—muscle cancer	0.000119	0.000906	CcSEcCtD
Carbamazepine—Dizziness—Etoposide—muscle cancer	0.000119	0.000905	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—muscle cancer	0.000118	0.000902	CcSEcCtD
Carbamazepine—Vertigo—Methotrexate—muscle cancer	0.000118	0.000902	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000118	0.0009	CcSEcCtD
Carbamazepine—Leukopenia—Methotrexate—muscle cancer	0.000118	0.000899	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—muscle cancer	0.000118	0.000896	CcSEcCtD
Carbamazepine—Arrhythmia—Doxorubicin—muscle cancer	0.000117	0.000892	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—muscle cancer	0.000116	0.000883	CcSEcCtD
Carbamazepine—Mental disorder—Doxorubicin—muscle cancer	0.000115	0.000875	CcSEcCtD
Carbamazepine—Convulsion—Methotrexate—muscle cancer	0.000114	0.00087	CcSEcCtD
Carbamazepine—Vomiting—Etoposide—muscle cancer	0.000114	0.00087	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—muscle cancer	0.000114	0.00087	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—muscle cancer	0.000114	0.00087	CcSEcCtD
Carbamazepine—Rash—Etoposide—muscle cancer	0.000113	0.000863	CcSEcCtD
Carbamazepine—Dermatitis—Etoposide—muscle cancer	0.000113	0.000862	CcSEcCtD
Carbamazepine—Headache—Etoposide—muscle cancer	0.000113	0.000857	CcSEcCtD
Carbamazepine—Chest pain—Methotrexate—muscle cancer	0.000112	0.000855	CcSEcCtD
Carbamazepine—Arthralgia—Methotrexate—muscle cancer	0.000112	0.000855	CcSEcCtD
Carbamazepine—Myalgia—Methotrexate—muscle cancer	0.000112	0.000855	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—muscle cancer	0.000112	0.000853	CcSEcCtD
Carbamazepine—Dysgeusia—Doxorubicin—muscle cancer	0.000112	0.000852	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000111	0.000849	CcSEcCtD
Carbamazepine—Nervousness—Doxorubicin—muscle cancer	0.000111	0.000845	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—muscle cancer	0.00011	0.000841	CcSEcCtD
Carbamazepine—Muscle spasms—Doxorubicin—muscle cancer	0.00011	0.000836	CcSEcCtD
Carbamazepine—Confusional state—Methotrexate—muscle cancer	0.000108	0.000826	CcSEcCtD
Carbamazepine—Anaphylactic shock—Methotrexate—muscle cancer	0.000108	0.00082	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—muscle cancer	0.000108	0.00082	CcSEcCtD
Carbamazepine—Infection—Methotrexate—muscle cancer	0.000107	0.000814	CcSEcCtD
Carbamazepine—Nausea—Etoposide—muscle cancer	0.000107	0.000813	CcSEcCtD
Carbamazepine—Nervous system disorder—Methotrexate—muscle cancer	0.000106	0.000804	CcSEcCtD
Carbamazepine—Anaemia—Doxorubicin—muscle cancer	0.000106	0.000804	CcSEcCtD
Carbamazepine—Thrombocytopenia—Methotrexate—muscle cancer	0.000105	0.000802	CcSEcCtD
Carbamazepine—Agitation—Doxorubicin—muscle cancer	0.000105	0.000799	CcSEcCtD
Carbamazepine—Skin disorder—Methotrexate—muscle cancer	0.000105	0.000796	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methotrexate—muscle cancer	0.000104	0.000792	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—muscle cancer	0.000103	0.000781	CcSEcCtD
Carbamazepine—Anorexia—Methotrexate—muscle cancer	0.000103	0.000781	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—muscle cancer	0.000102	0.00078	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—muscle cancer	0.000102	0.000778	CcSEcCtD
Carbamazepine—Hypotension—Methotrexate—muscle cancer	0.000101	0.000766	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—muscle cancer	0.0001	0.000764	CcSEcCtD
Carbamazepine—Convulsion—Doxorubicin—muscle cancer	9.89e-05	0.000753	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—muscle cancer	9.86e-05	0.000751	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Methotrexate—muscle cancer	9.8e-05	0.000747	CcSEcCtD
Carbamazepine—ABCB1—bone marrow—muscle cancer	9.75e-05	0.00727	CbGeAlD
Carbamazepine—Insomnia—Methotrexate—muscle cancer	9.73e-05	0.000741	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—muscle cancer	9.72e-05	0.00074	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—muscle cancer	9.72e-05	0.00074	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—muscle cancer	9.72e-05	0.00074	CcSEcCtD
Carbamazepine—Anxiety—Doxorubicin—muscle cancer	9.69e-05	0.000738	CcSEcCtD
Carbamazepine—Paraesthesia—Methotrexate—muscle cancer	9.66e-05	0.000736	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	9.65e-05	0.000735	CcSEcCtD
Carbamazepine—Dyspnoea—Methotrexate—muscle cancer	9.59e-05	0.000731	CcSEcCtD
Carbamazepine—Somnolence—Methotrexate—muscle cancer	9.57e-05	0.000729	CcSEcCtD
Carbamazepine—Dry mouth—Doxorubicin—muscle cancer	9.51e-05	0.000724	CcSEcCtD
Carbamazepine—Dyspepsia—Methotrexate—muscle cancer	9.47e-05	0.000721	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—muscle cancer	9.39e-05	0.000716	CcSEcCtD
Carbamazepine—Decreased appetite—Methotrexate—muscle cancer	9.35e-05	0.000712	CcSEcCtD
Carbamazepine—ABCB1—vagina—muscle cancer	9.34e-05	0.00696	CbGeAlD
Carbamazepine—Anaphylactic shock—Doxorubicin—muscle cancer	9.32e-05	0.00071	CcSEcCtD
Carbamazepine—Oedema—Doxorubicin—muscle cancer	9.32e-05	0.00071	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Methotrexate—muscle cancer	9.29e-05	0.000708	CcSEcCtD
Carbamazepine—Fatigue—Methotrexate—muscle cancer	9.28e-05	0.000707	CcSEcCtD
Carbamazepine—Infection—Doxorubicin—muscle cancer	9.26e-05	0.000705	CcSEcCtD
Carbamazepine—Pain—Methotrexate—muscle cancer	9.2e-05	0.000701	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—muscle cancer	9.17e-05	0.000698	CcSEcCtD
Carbamazepine—Nervous system disorder—Doxorubicin—muscle cancer	9.14e-05	0.000696	CcSEcCtD
Carbamazepine—Thrombocytopenia—Doxorubicin—muscle cancer	9.12e-05	0.000695	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—muscle cancer	9.09e-05	0.000693	CcSEcCtD
Carbamazepine—Skin disorder—Doxorubicin—muscle cancer	9.05e-05	0.000689	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—muscle cancer	9.01e-05	0.000686	CcSEcCtD
Carbamazepine—Anorexia—Doxorubicin—muscle cancer	8.88e-05	0.000677	CcSEcCtD
Carbamazepine—Feeling abnormal—Methotrexate—muscle cancer	8.87e-05	0.000675	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methotrexate—muscle cancer	8.8e-05	0.00067	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—muscle cancer	8.71e-05	0.000663	CcSEcCtD
Carbamazepine—ABCB1—head—muscle cancer	8.63e-05	0.00643	CbGeAlD
Carbamazepine—Urticaria—Methotrexate—muscle cancer	8.55e-05	0.000651	CcSEcCtD
Carbamazepine—Abdominal pain—Methotrexate—muscle cancer	8.51e-05	0.000648	CcSEcCtD
Carbamazepine—Body temperature increased—Methotrexate—muscle cancer	8.51e-05	0.000648	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	8.49e-05	0.000647	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—muscle cancer	8.43e-05	0.000642	CcSEcCtD
Carbamazepine—Paraesthesia—Doxorubicin—muscle cancer	8.37e-05	0.000637	CcSEcCtD
Carbamazepine—ABCB1—testis—muscle cancer	8.34e-05	0.00621	CbGeAlD
Carbamazepine—Dyspnoea—Doxorubicin—muscle cancer	8.31e-05	0.000633	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—muscle cancer	8.28e-05	0.000631	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—muscle cancer	8.2e-05	0.000625	CcSEcCtD
Carbamazepine—Decreased appetite—Doxorubicin—muscle cancer	8.1e-05	0.000617	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—muscle cancer	8.04e-05	0.000613	CcSEcCtD
Carbamazepine—Fatigue—Doxorubicin—muscle cancer	8.03e-05	0.000612	CcSEcCtD
Carbamazepine—Pain—Doxorubicin—muscle cancer	7.97e-05	0.000607	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—muscle cancer	7.97e-05	0.000607	CcSEcCtD
Carbamazepine—Hypersensitivity—Methotrexate—muscle cancer	7.93e-05	0.000604	CcSEcCtD
Carbamazepine—Asthenia—Methotrexate—muscle cancer	7.72e-05	0.000588	CcSEcCtD
Carbamazepine—Feeling abnormal—Doxorubicin—muscle cancer	7.68e-05	0.000585	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Doxorubicin—muscle cancer	7.62e-05	0.00058	CcSEcCtD
Carbamazepine—Pruritus—Methotrexate—muscle cancer	7.61e-05	0.00058	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—muscle cancer	7.4e-05	0.000564	CcSEcCtD
Carbamazepine—Abdominal pain—Doxorubicin—muscle cancer	7.37e-05	0.000561	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—muscle cancer	7.37e-05	0.000561	CcSEcCtD
Carbamazepine—Diarrhoea—Methotrexate—muscle cancer	7.36e-05	0.000561	CcSEcCtD
Carbamazepine—Dizziness—Methotrexate—muscle cancer	7.12e-05	0.000542	CcSEcCtD
Carbamazepine—Hypersensitivity—Doxorubicin—muscle cancer	6.86e-05	0.000523	CcSEcCtD
Carbamazepine—Vomiting—Methotrexate—muscle cancer	6.84e-05	0.000521	CcSEcCtD
Carbamazepine—Rash—Methotrexate—muscle cancer	6.78e-05	0.000517	CcSEcCtD
Carbamazepine—Dermatitis—Methotrexate—muscle cancer	6.78e-05	0.000516	CcSEcCtD
Carbamazepine—Headache—Methotrexate—muscle cancer	6.74e-05	0.000513	CcSEcCtD
Carbamazepine—Asthenia—Doxorubicin—muscle cancer	6.69e-05	0.000509	CcSEcCtD
Carbamazepine—Pruritus—Doxorubicin—muscle cancer	6.59e-05	0.000502	CcSEcCtD
Carbamazepine—Nausea—Methotrexate—muscle cancer	6.39e-05	0.000487	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—muscle cancer	6.38e-05	0.000486	CcSEcCtD
Carbamazepine—Dizziness—Doxorubicin—muscle cancer	6.16e-05	0.000469	CcSEcCtD
Carbamazepine—Vomiting—Doxorubicin—muscle cancer	5.92e-05	0.000451	CcSEcCtD
Carbamazepine—Rash—Doxorubicin—muscle cancer	5.87e-05	0.000447	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—muscle cancer	5.87e-05	0.000447	CcSEcCtD
Carbamazepine—Headache—Doxorubicin—muscle cancer	5.84e-05	0.000445	CcSEcCtD
Carbamazepine—Nausea—Doxorubicin—muscle cancer	5.53e-05	0.000422	CcSEcCtD
